Abstract
dc:description.abstractInterpretation Differences in brain structure and function are evident between patients who developed CIPN and those who did not. Crucially, the regions identified, in particular the NAc, have been postulated to denote a vulnerability for progression to pain states. Although the findings need further confirmation they suggest a paradigm shift in terms of CIPN as a clinical problem. Specifically, it appears that certain individuals can be considered as having increased risk of CIPN development prior to chemotherapy administration. This risk relates to the baseline structure, and function of their brains. Finally, the set up of the MINT3 fMRI study showed that this kind of study design is acceptable in terms of ethical and R&D approvals and a single healthy volunteer pilot. Preliminary work in the Adams Lab has provided evidence for an age-related separation of chromatids in dictyate oocytes from older mice. To determine the separation of chromatids and infer chromosome cohesion levels in dictyate human oocytes, I used Fluorescence in situ Hybridisation (FISH) to fluorescently label specific chromosomal regions. Using human ovary sections from fertility preservation patients and Caesarian section patients, I investigated if the age-related separation of chromatids was conserved in humans. I measured the distances between each FISH signal to quantify inter-chromatid separation in each oocyte. My analysis revealed an increase in inter-chromatid distances at telomereadjacent regions of chromosome 13, 16 and 21 with increasing maternal age, which are amongst the most common chromosome aneuploidies in human genetic disease and miscarriages. Next, I assessed whether changes in chromosome-associated cohesin may relate to this separation. Whilst previous work in human oocytes have not reliably shown any changes in cohesin protein levels with maternal age, it is possible that these changes are occurring in specific cohesin subunits yet to be identified. In mitotic cells, the acetylation of SMC3 stabilises chromosome-bound cohesin involved in sister chromatid cohesion, thus marking a subpopulation of ‘cohesive’ cohesin. Additionally, in Tex19.1⁻/⁻ oocytes, cohesion loss was accompanied by a decrease in AcSMC3 but not REC8, suggesting that AcSMC3 may be more representative of cohesion changes. Indeed, I found a drastic decline in nuclear AcSMC3 in dictyate oocytes from older women. For the first time in human oocytes, my data shows an age-related decrease in inter-chromatid cohesion, corresponding to changes in the cohesive cohesin, AcSMC3. Alongside age-dependent changes in cohesion during dictyate arrest, additional pathways have been implicated in further cohesion loss in the post-dictyate stages of oogenesis. Enhancing cohesion levels in these later stages has the potential to improve aneuploidy outcomes in oocytes, so I took both a genetic and pharmacological approach to attempt to manipulate cohesion levels. TEX19.1 is a protein that regulates AcSMC3 levels and maintains cohesion levels in oocytes, likely by negatively regulating its partner UBR2, an E3 ubiquitin ligase. However, I found that neither Ubr2⁻/⁻ nor Ubr2 separation of function mutations affect chromosome cohesion in mouse oocytes. It is likely that the regulation of cohesion by a TEX19.1-UBR2 pathway in post-dictyate oocytes is more complex than in somatic tissues, possibly due to the activity of other UBR proteins in oocytes. In old mouse oocytes with depleted cohesin levels, sufficient cohesion remains to keep bivalents intact. However, once the bivalent is pulled by the spindle in prometaphase, chromosomes begin to separate prematurely. This suggests that an alternative pathway may contribute to chromosome cohesion loss in oocytes during prometaphase. To determine if the attachment of spindle fibres that applies tension across the bivalent contributes to cohesion loss, I treated mouse oocytes with various spindle drugs to assess the effects on chromosome cohesion. In the absence of a bipolar spindle, oocytes exhibited more proximally positioned chiasma in metaphase I with higher levels of AcSMC3 on their chromosomes, suggesting that spindle drug treatment prevents chromosomes from ‘ageing’ and instead resemble chromosomes from a ‘younger’ oocyte. Further investigation into the molecular players involved in a spindle-induced cohesion loss pathway may provide a therapeutic route to enhance cohesion and improve oocyte quality during fertility treatment.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bui, Matilda
- Advisors dc:contributor.advisor
-
- Adams, Ian
- Sproul, Duncan
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/4532